Gilead Sciences, Inc. today announced new data from multiple analyses which reinforce that Livdelzi® (seladelpar), known as Lyvdelzi® in the European Union, is effective and generally well-tolerated ...

Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The ...

Adequate biliary drainage should remain the principal aim of cholangiography. In the absence of clear evidence of systemic sepsis, antibiotics should not be prescribed or changed purely according ...

Georgia Southwestern University Georgia Southwestern State University (GSW) hosted its 7th Annual Undergraduate Research ...

Cash and cash equivalents totaled €81.8 million as of December 31, 2024. In addition, completion in early 2025 of: (i) a non-dilutive royalty financing agreement for up to €185 million including a fir ...

This study positions platelet-related biomarkers as practical, cost-effective tools for early risk stratification in biliary sepsis. For hospitalists, infectious disease specialists, and critical care ...

Skye, 11 months old, was born with biliary atresia ... the brave boy first presented to the RCH with “life-threatening sepsis,” adding: “He was as sick as you can get.” ...

Biliary stasis inhibits the continuous flushing activity of ... bacteria and toxins out of the ducts and into the systemic circulation, which can result in sepsis. Sepsis is among the most common ...

Information on postoperative complications of patients was obtained, including biliary pancreatitis, incision infections, pulmonary infections, sepsis/septic shock and death. Data on patients’ gender, ...